EPISODE · May 16, 2025 · 24 MIN
Laminar Pharma avanza en su lucha contra el cáncer
from Biotecnología Capital · host Capital Radio
Hablamos con Paula Fernández doctora en Bioquímica y Biología Molecular y directora científica de Laminar Pharma para conocer los detalles del estudio CLINGLIO con su compuesto LAM561 para la lucha contra el glioblastoma.
Embed this episode
NOW PLAYING
Laminar Pharma avanza en su lucha contra el cáncer
0:00
24:13
1×
No transcript for this episode yet
Similar Episodes
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Biotecnología Capital?
This episode is 24 minutes long.
When was this Biotecnología Capital episode published?
This episode was published on May 16, 2025.
Can I download this Biotecnología Capital episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!